The Patent Finder

Bavarian Nordic A/S

Also on record
Records under this name other than the patents Bavarian Nordic A/S holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 60 patents it holds.

Back to Bavarian Nordic A/S

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 10,561,722Methods and Compositions for Enhancing Immune Responses
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 8,808,709Use of a modified poxvirus for the rapid induction of immunity against a poxvirus or other infectious agents
Term ended
Term ended Nov 9, 2026 · USPTO record
Term endedTerm ended Nov 9, 2026USPTO record
US 8,859,257Vaccinia Virus Mutants Containing the Major Genomic Deletions of Mva
No holder on record
Lapsed on the fee record
Ended Oct 14, 2026 · High confidence
Lapsed on the fee recordEnded Oct 14, 2026High confidence
US 9,265,823Use of a modified poxvirus for the rapid induction of immunity against a poxvirus or other infectious agents
Term ended
Ended no later than Feb 17, 2026 · USPTO record
Term endedEnded no later than Feb 17, 2026USPTO record
US 11,173,204MVA-BN and Ad26.ZEBOV or Ad26.filo prime-boost regimen
Lapsed on the fee record
Ended Nov 16, 2025 · USPTO record
Lapsed on the fee recordEnded Nov 16, 2025USPTO record
US 7,695,939Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions
Term ended
Term ended Aug 23, 2025 · USPTO record
Term endedTerm ended Aug 23, 2025USPTO record
US 9,717,787Recombinant modified vaccinia virus ankara (MVA) respiratory syncytial virus (RSV) vaccine
Lapsed on the fee record
Ended Aug 1, 2025 · USPTO record
Lapsed on the fee recordEnded Aug 1, 2025USPTO record
US 11,020,476Methods and Compositions for Inducing an Immune Response Against Hepatitis B Virus (HBV)
Formerly held
Lapsed on the fee record
Ended Jun 1, 2025 · High confidence
Lapsed on the fee recordEnded Jun 1, 2025High confidence
US 10,946,089Recombinant modified vaccinia virus ankara (MVA) respiratory syncytial virus (RSV) vaccine
Lapsed on the fee record
Ended Mar 16, 2025 · USPTO record
Lapsed on the fee recordEnded Mar 16, 2025USPTO record
US 10,925,956Methods and compositions for inducing protective immunity against a marburg virus infection
Lapsed on the fee record
Ended Feb 23, 2025 · USPTO record
Lapsed on the fee recordEnded Feb 23, 2025USPTO record
10 of 90 patents shown.
Pro members see all 90.
Pro members: see all 90 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited